These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 1520841
1. Chronobiologic response modifiers and breast cancer development: classical background and chronobiologic tasks remaining. Cornélissen G, Halberg F. In Vivo; 1992; 6(4):387-402. PubMed ID: 1520841 [Abstract] [Full Text] [Related]
2. Toward chronobiologic pattern discrimination of the risk of developing breast cancer and other diseases. Hermida Domínguez RC, Halberg F, del Pozo F, Haus E. Rev Esp Oncol; 1982; 29(2):199-267. PubMed ID: 6765184 [Abstract] [Full Text] [Related]
6. Human relevance of rodent prolactin-induced non-genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments. Harvey PW. J Appl Toxicol; 2005; 25(3):179-83. PubMed ID: 15856525 [Abstract] [Full Text] [Related]
7. From experimental units to unique experiments: chronobiologic pilots complement large trials. Halberg F, Cornélissen G, Bingham C, Fujii S, Halberg E. In Vivo; 1992; 6(4):403-27. PubMed ID: 1520842 [Abstract] [Full Text] [Related]
8. Clinical trials: the larger the better? Halberg F, Bingham C, Cornélissen G. Chronobiologia; 1993; 20(3-4):193-211. PubMed ID: 8131669 [Abstract] [Full Text] [Related]
10. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer. Thun-Battersby S, Mevissen M, Löscher W. Cancer Res; 1999 Aug 01; 59(15):3627-33. PubMed ID: 10446973 [Abstract] [Full Text] [Related]
16. Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors. Wagner CR, Ballato G, Akanni AO, McIntee EJ, Larson RS, Chang S, Abul-Hajj YJ. Cancer Res; 1997 Jun 15; 57(12):2341-5. PubMed ID: 9192804 [Abstract] [Full Text] [Related]
17. Secular or circannual effects of placebo and melatonin on murine breast cancer? Wrba H, Dutter A, Sánchez de la Peña S, Wu J, Carandente F, Cornélissen G, Halberg F. Prog Clin Biol Res; 1990 Jun 15; 341A():31-40. PubMed ID: 2217247 [No Abstract] [Full Text] [Related]
18. Rhythmic pineal-hypophyseal-adrenal intermodulations ex vivo. Sánchez de la Peña S, Halberg F, Lakatua D, Ungar F. Prog Clin Biol Res; 1987 Jun 15; 227A():421-49. PubMed ID: 3037558 [Abstract] [Full Text] [Related]
19. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Carcinogenesis; 2005 Jul 15; 26(7):1241-6. PubMed ID: 15790588 [Abstract] [Full Text] [Related]
20. Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM, Hrushesky WJ. Breast Cancer Res Treat; 2009 Sep 15; 117(2):423-31. PubMed ID: 18651214 [Abstract] [Full Text] [Related] Page: [Next] [New Search]